In contrast to the pro-angiogenic effects of TGF-β in tumor cells, we observed that loss of TGF-β signaling in ECs led to increased expression of VEGFA and angiopoietin-1, suggesting distinct mechanisms within the endothelial compartment. Here, TGFB1 is linked to neoplasm.